Details for New Drug Application (NDA): 084015
The generic ingredient in BLEPH-10 is sulfacetamide sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 084015
| Tradename: | BLEPH-10 |
| Applicant: | Allergan |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084015
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
